There are currently no known outstanding effects for the The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020, Paragraph 52.
52. For regulation 69 (amendment of regulation 64 (duties of licensing authority in connection with determination)) substitute—U.K.
“69. For regulation 64(4)(d) substitute—
“(d)any conditions—
(i)in the case of a UKMA(NI) or UKMA(UK), established in accordance with Articles 21a, 22 and 22a of the 2001 Directive;
(ii)in the case of UKMA(GB), imposed under regulations 59 to 61; and”.”.
Commencement Information
I1Sch. 2 para. 52 in force at 31.12.2020 immediately before IP completion day, see reg. 1
All content is available under the Open Government Licence v3.0 except where otherwise stated. This site additionally contains content derived from EUR-Lex, reused under the terms of the Commission Decision 2011/833/EU on the reuse of documents from the EU institutions. For more information see the EUR-Lex public statement on re-use.
